FDA.reportPublic FDA data

24 HR diazoxide choline 25 MG Extended Release Oral Tablet

RxCUI
2711559
RxNorm name
24 HR diazoxide choline 25 MG Extended Release Oral Tablet
Display name
24 HR diazoxide choline 25 MG Extended Release Oral Tablet
Full name
24 HR diazoxide choline 25 MG Extended Release Oral Tablet
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:38:47

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
VYKAT XRDIAZOXIDE CHOLINESoleno Therapeutics, Inc.0e745e85-9512-e360-e063-6394a90aebf12025-03-26Warnings, Adverse reactionsExact identifier
rxcui: 2711559

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
0e745e85-9512-e360-e063-6394a90aebf1diazoxide choline 25 MG 24HR Extended Release Oral Tablet [PSN] · 24 HR diazoxide choline 25 MG Extended Release Oral Tablet [SCD] · diazoxide choline 25 MG 24 HR Extended Release Oral Tablet [SY]32These highlights do not include all the information needed to use VYKAT XR safely and effectively. See full prescribing information for VYKAT XR. VYKAT ™ XR (diazoxide choline) extended-release tablets, for oral use Initial U.S. Approval: 197320250326